A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Clinical trial NCT06291220 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06291220
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-27
- Primary completion
- 2027-07-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.